Objective: To determine the prevalence of measles seronegativity among infants younger
than 6 months and to ascertain their serologic response to measles vaccine. Design: Cross …

Materials and methods. Study population. Sera from pregnant women seen for pregnancy
care during 1997 in the General Direction of Medical Specialities (Northern area) in …

A measles epidemic in San Antonio, Texas provided a population of children who were
immunized at≤ 10 months of age and reimmunized at≥ 15 months of age. Of these …

BACKGROUND: Previous studies have suggested that girls may have lower maternal
measles antibody levels than boys. Girls might therefore be more likely to contract measles …

Abstract Dabis F (International Health Program Office, CDC, Atlanta, GA 30333, USA),
Waldman RJ, Mann GF, Commenges D, Madzou G and Jones T S. Loss of maternal …

The antibody response to attenuated live measles vaccines was studied in two groups of 29
(A) and 53 (B) African children. In group A 22 sera and in group B 34 sera showed no pre …

Objectives. The goals of this study were to evaluate the proportion of previously vaccinated
human immunodeficiency virus (HIV) type 1-infected children with detectable …

Immunizing infants against measles at the youngest age possible has the potential to reduce
morbidity and mortality. The ability of infants at 6, 9, or 12 months to respond to measles and …

Children immunized with 4 doses of formalin‐inactivated vaccine and/or purified
hemagglutinin prepared from Tween 80‐ether (TE) treated material were subjected to a …

Since the measles, mumps and rubella (MMR) vaccine was introduced into Sweden in 1982,
a yearly evaluation of the immunity patterns and sero-conversion rates in 12-year-old …